{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:27:28Z","timestamp":1776148048627,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/MULTI\/04046\/2013"],"award-info":[{"award-number":["UID\/MULTI\/04046\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BIA-CEL\/28408\/2017"],"award-info":[{"award-number":["PTDC\/BIA-CEL\/28408\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/52488\/2014"],"award-info":[{"award-number":["SFRH\/BD\/52488\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/94322\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/94322\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00018-020-03448-4","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T06:02:50Z","timestamp":1579759370000},"page":"4997-5015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A SYK\/SHC1 pathway regulates the amount of CFTR in the plasma membrane"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-3285","authenticated-orcid":false,"given":"Cl\u00e1udia Almeida","family":"Loureiro","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-0054","authenticated-orcid":false,"given":"Francisco R.","family":"Pinto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5063-5766","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Barros","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-9696","authenticated-orcid":false,"given":"Paulo","family":"Matos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-9211","authenticated-orcid":false,"given":"Peter","family":"Jordan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"3448_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/humu.10041","volume":"19","author":"JL Bobadilla","year":"2002","unstructured":"Bobadilla JL, Macek M, Fine JP, Farrell PM (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations\u2014correlation with incidence data and application to screening. Hum Mutat 19:575\u2013606. https:\/\/doi.org\/10.1002\/humu.10041","journal-title":"Hum Mutat"},{"key":"3448_CR2","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1056\/NEJMra043184","volume":"352","author":"SM Rowe","year":"2005","unstructured":"Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352:1992\u20132001. https:\/\/doi.org\/10.1056\/NEJMra043184","journal-title":"N Engl J Med"},{"key":"3448_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq V, Gray MA (2017) Role of CFTR in epithelial physiology. Cell Mol Life Sci 74:93\u2013115. https:\/\/doi.org\/10.1007\/s00018-016-2391-y","journal-title":"Cell Mol Life Sci"},{"key":"3448_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00063198-200311000-00007","volume":"9","author":"SH Donaldson","year":"2003","unstructured":"Donaldson SH, Boucher RC (2003) Update on pathogenesis of cystic fibrosis lung disease. Curr Opin Pulm Med 9:486\u2013491","journal-title":"Curr Opin Pulm Med"},{"key":"3448_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.biocel.2014.03.011","volume":"52","author":"C Ehre","year":"2014","unstructured":"Ehre C, Ridley C, Thornton DJ (2014) Cystic fibrosis: an inherited disease affecting mucin-producing organs. Int J Biochem Cell Biol 52:136\u2013145. https:\/\/doi.org\/10.1016\/j.biocel.2014.03.011","journal-title":"Int J Biochem Cell Biol"},{"key":"3448_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","volume":"77","author":"JR Riordan","year":"2008","unstructured":"Riordan JR (2008) CFTR Function and Prospects for Therapy. Annu Rev Biochem 77:701\u2013726. https:\/\/doi.org\/10.1146\/annurev.biochem.75.103004.142532","journal-title":"Annu Rev Biochem"},{"key":"3448_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","volume":"169","author":"F Liu","year":"2017","unstructured":"Liu F, Zhang Z, Csan\u00e1dy L et al (2017) Molecular structure of the human CFTR ion channel. Cell 169:85\u201395.e8. https:\/\/doi.org\/10.1016\/j.cell.2017.02.024","journal-title":"Cell"},{"key":"3448_CR8","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2174\/13816128113199990318","volume":"19","author":"MD Amaral","year":"2013","unstructured":"Amaral MD, Farinha CM (2013) Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis. Curr Pharm Des 19:3497\u20133508. https:\/\/doi.org\/10.2174\/13816128113199990318","journal-title":"Curr Pharm Des"},{"key":"3448_CR9","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1111\/febs.12392","volume":"280","author":"CM Farinha","year":"2013","unstructured":"Farinha CM, Matos P, Amaral MD (2013) Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the golgi. FEBS J 280:4396\u20134406. https:\/\/doi.org\/10.1111\/febs.12392","journal-title":"FEBS J"},{"key":"3448_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pharmthera.2014.06.005","volume":"145","author":"SC Bell","year":"2015","unstructured":"Bell SC, De Boeck K, Amaral MD (2015) New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther 145:19\u201334. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.06.005","journal-title":"Pharmacol Ther"},{"key":"3448_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","volume":"67","author":"JP Clancy","year":"2012","unstructured":"Clancy JP, Rowe SM, Accurso FJ et al (2012) Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax 67:12\u201318. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200393","journal-title":"Thorax"},{"key":"3448_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/17476348.2018.1507741","volume":"12","author":"MA Sala","year":"2018","unstructured":"Sala MA, Jain M (2018) Tezacaftor for the treatment of cystic fibrosis. Expert Rev Respir Med 12:725\u2013732. https:\/\/doi.org\/10.1080\/17476348.2018.1507741","journal-title":"Expert Rev Respir Med"},{"key":"3448_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1358\/dot.2016.52.4.2467205","volume":"52","author":"W Zhang","year":"2016","unstructured":"Zhang W, Zhang X, Zhang YH et al (2016) Lumacaftor\/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR. Drugs Today 52:229\u2013237. https:\/\/doi.org\/10.1358\/dot.2016.52.4.2467205","journal-title":"Drugs Today"},{"key":"3448_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.29245\/2689-999X\/2017\/1.1113","volume":"2","author":"A Matos","year":"2018","unstructured":"Matos A, Matos P (2018) Combination therapy in Phe508del CFTR: how many will be enough? J Lung Health Dis 2:9\u201316","journal-title":"J Lung Health Dis"},{"key":"3448_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/joim.12314","volume":"277","author":"MD Amaral","year":"2015","unstructured":"Amaral MD (2015) Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients. J Intern Med 277:155\u2013166. https:\/\/doi.org\/10.1111\/joim.12314","journal-title":"J Intern Med"},{"key":"3448_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/febs.13531","volume":"283","author":"CM Farinha","year":"2016","unstructured":"Farinha CM, Matos P (2016) Repairing the basic defect in cystic fibrosis\u2014one approach is not enough. FEBS J 283:246\u2013264. https:\/\/doi.org\/10.1111\/febs.13531","journal-title":"FEBS J"},{"key":"3448_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrm1949","volume":"7","author":"WB Guggino","year":"2006","unstructured":"Guggino WB, Stanton BA (2006) New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 7:426\u2013436. https:\/\/doi.org\/10.1038\/nrm1949","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3448_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1021\/cb300484r","volume":"8","author":"S Moniz","year":"2013","unstructured":"Moniz S, Sousa M, Moraes BJ et al (2013) HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR. ACS Chem Biol 8:432\u2013442. https:\/\/doi.org\/10.1021\/cb300484r","journal-title":"ACS Chem Biol"},{"key":"3448_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2016.00001","volume":"4","author":"CM Farinha","year":"2016","unstructured":"Farinha CM, Swiatecka-Urban A, Brautigan DL, Jordan P (2016) Regulatory crosstalk by protein kinases on CFTR trafficking and activity. Front Chem 4:1. https:\/\/doi.org\/10.3389\/fchem.2016.00001","journal-title":"Front Chem"},{"key":"3448_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00018-016-2387-7","volume":"74","author":"CM Farinha","year":"2017","unstructured":"Farinha CM, Canato S (2017) From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking. Cell Mol Life Sci 74:39\u201355. https:\/\/doi.org\/10.1007\/s00018-016-2387-7","journal-title":"Cell Mol Life Sci"},{"key":"3448_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/21541248.2017.1317700","volume":"9","author":"CM Farinha","year":"2018","unstructured":"Farinha CM, Matos P (2018) Rab GTPases regulate the trafficking of channels and transporters\u2014a focus on cystic fibrosis. Small GTPases 9:136\u2013144. https:\/\/doi.org\/10.1080\/21541248.2017.1317700","journal-title":"Small GTPases"},{"key":"3448_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/19336950.2015.1126010","volume":"10","author":"A Billet","year":"2016","unstructured":"Billet A, Jia Y, Jensen TJ et al (2016) Potential sites of CFTR activation by tyrosine kinases. Channels 10:247\u2013251. https:\/\/doi.org\/10.1080\/19336950.2015.1126010","journal-title":"Channels"},{"key":"3448_CR23","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1096\/fj.15-273151","volume":"29","author":"A Billet","year":"2015","unstructured":"Billet A, Jia Y, Jensen T et al (2015) Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation. FASEB J 29:3945\u20133953. https:\/\/doi.org\/10.1096\/fj.15-273151","journal-title":"FASEB J"},{"key":"3448_CR24","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1128\/MCB.05152-11","volume":"31","author":"AI Mendes","year":"2011","unstructured":"Mendes AI, Matos P, Moniz S et al (2011) Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase. Mol Cell Biol 31:4076\u20134086. https:\/\/doi.org\/10.1128\/MCB.05152-11","journal-title":"Mol Cell Biol"},{"key":"3448_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nri2765","volume":"10","author":"A M\u00f3csai","year":"2010","unstructured":"M\u00f3csai A, Ruland J, Tybulewicz VLJ (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10:387\u2013402. https:\/\/doi.org\/10.1038\/nri2765","journal-title":"Nat Rev Immunol"},{"key":"3448_CR26","doi-asserted-by":"publisher","first-page":"L497","DOI":"10.1152\/ajplung.00246.2004","volume":"288","author":"M Ulanova","year":"2005","unstructured":"Ulanova M, Puttagunta L, Marcet-Palacios M et al (2005) Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 288:L497\u2013507. https:\/\/doi.org\/10.1152\/ajplung.00246.2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3448_CR27","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.4049\/jimmunol.177.10.6859","volume":"177","author":"X Wang","year":"2006","unstructured":"Wang X, Lau C, Wiehler S et al (2006) Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells. J Immunol 177:6859\u20136870. https:\/\/doi.org\/10.4049\/jimmunol.177.10.6859","journal-title":"J Immunol"},{"key":"3448_CR28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0960-9822(01)00565-6","volume":"11","author":"DG Woodside","year":"2001","unstructured":"Woodside DG, Obergfell A, Leng L et al (2001) Activation of Syk protein tyrosine kinase through interaction with integrin \u03b2 cytoplasmic domains. Curr Biol 11:1799\u20131804. https:\/\/doi.org\/10.1016\/S0960-9822(01)00565-6","journal-title":"Curr Biol"},{"key":"3448_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000149783","volume":"22","author":"B Illek","year":"2008","unstructured":"Illek B, Maurisse R, Wahler L et al (2008) Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels. Cell Physiol Biochem 22:57\u201368. https:\/\/doi.org\/10.1159\/000149783","journal-title":"Cell Physiol Biochem"},{"key":"3448_CR30","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1038\/srep09038","volume":"5","author":"HM Botelho","year":"2015","unstructured":"Botelho HM, Uliyakina I, Awatade NT et al (2015) Protein traffic disorders: an effective high-throughput fluorescence microscopy pipeline for drug discovery. Sci Rep 5:9038. https:\/\/doi.org\/10.1038\/srep09038","journal-title":"Sci Rep"},{"key":"3448_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","volume":"499","author":"LJV Galietta","year":"2001","unstructured":"Galietta LJV, Haggie PM, Verkman AS (2001) Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett 499:220\u2013224. https:\/\/doi.org\/10.1016\/S0014-5793(01)02561-3","journal-title":"FEBS Lett"},{"key":"3448_CR32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008738","author":"AM Matos","year":"2019","unstructured":"Matos AM, Pinto FR, Barros P et al (2019) Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA119.008738","journal-title":"J Biol Chem"},{"key":"3448_CR33","doi-asserted-by":"publisher","first-page":"ra48","DOI":"10.1126\/scisignal.aaa1580","volume":"8","author":"CA Loureiro","year":"2015","unstructured":"Loureiro CA, Matos AM, Dias-Alves \u00c2 et al (2015) A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint. Sci Signal 8:ra48. https:\/\/doi.org\/10.1126\/scisignal.aaa1580","journal-title":"Sci Signal"},{"key":"3448_CR34","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cellsig.2009.03.007","volume":"21","author":"L Carsetti","year":"2009","unstructured":"Carsetti L, Laurenti L, Gobessi S et al (2009) Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation. Cell Signal 21:1187\u20131194. https:\/\/doi.org\/10.1016\/j.cellsig.2009.03.007","journal-title":"Cell Signal"},{"key":"3448_CR35","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1074\/jbc.M309909200","volume":"279","author":"WX Schulze","year":"2004","unstructured":"Schulze WX, Mann M (2004) A novel proteomic screen for peptide\u2013protein interactions. J Biol Chem 279:10756\u201310764. https:\/\/doi.org\/10.1074\/jbc.M309909200","journal-title":"J Biol Chem"},{"key":"3448_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/363083a0","volume":"363","author":"M Rozakis-Adcock","year":"1993","unstructured":"Rozakis-Adcock M, Fernley R, Wade J et al (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363:83\u201385. https:\/\/doi.org\/10.1038\/363083a0","journal-title":"Nature"},{"key":"3448_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrm759","volume":"3","author":"MB Yaffe","year":"2002","unstructured":"Yaffe MB (2002) Phosphotyrosine-binding domains in signal transduction. Nat Rev Mol Cell Biol 3:177\u2013186. https:\/\/doi.org\/10.1038\/nrm759","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3448_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/360689a0","volume":"360","author":"M Rozakis-Adcock","year":"1992","unstructured":"Rozakis-Adcock M, McGlade J, Mbamalu G et al (1992) Association of the Shc and Grb2\/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689\u2013692. https:\/\/doi.org\/10.1038\/360689a0","journal-title":"Nature"},{"key":"3448_CR39","doi-asserted-by":"publisher","first-page":"RE12","DOI":"10.1126\/stke.2003.191.re12","volume":"2003","author":"J Schlessinger","year":"2003","unstructured":"Schlessinger J, Lemmon MA (2003) SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003:RE12. https:\/\/doi.org\/10.1126\/stke.2003.191.re12","journal-title":"Sci STKE"},{"key":"3448_CR40","doi-asserted-by":"publisher","first-page":"16268","DOI":"10.1074\/jbc.271.27.16268","volume":"271","author":"B Jabril-Cuenod","year":"1996","unstructured":"Jabril-Cuenod B, Zhang C, Scharenberg AM et al (1996) Syk-dependent phosphorylation of Shc: a potential link between Fc\u03f5RI and the Ras\/mitogen-activated protein kinase signaling pathway through SOS and Grb2. J Biol Chem 271:16268\u201316272. https:\/\/doi.org\/10.1074\/jbc.271.27.16268","journal-title":"J Biol Chem"},{"key":"3448_CR41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1073\/pnas.93.3.963","volume":"93","author":"P van der Geer","year":"1996","unstructured":"van der Geer P, Wiley S, Gish GD et al (1996) Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc Natl Acad Sci USA 93:963\u2013968. https:\/\/doi.org\/10.1073\/pnas.93.3.963","journal-title":"Proc Natl Acad Sci USA"},{"key":"3448_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1210\/mend.12.4.0094","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Okabayashi Y, Kido Y et al (1998) Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. Mol Endocrinol 12:536\u2013543. https:\/\/doi.org\/10.1210\/mend.12.4.0094","journal-title":"Mol Endocrinol"},{"key":"3448_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCRESAHA.110.233924","volume":"108","author":"RD Vanderlaan","year":"2011","unstructured":"Vanderlaan RD, Hardy WR, Kabir MG et al (2011) The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function. Circ Res 108:184\u2013193. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.233924","journal-title":"Circ Res"},{"key":"3448_CR44","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/358761a0","volume":"358","author":"GM Denning","year":"1992","unstructured":"Denning GM, Anderson MP, Amara JF et al (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761\u2013764. https:\/\/doi.org\/10.1038\/358761a0","journal-title":"Nature"},{"key":"3448_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00026.2001","volume":"82","author":"K Kunzelmann","year":"2002","unstructured":"Kunzelmann K, Mall M (2002) Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82:245\u2013289. https:\/\/doi.org\/10.1152\/physrev.00026.2001","journal-title":"Physiol Rev"},{"key":"3448_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2006.09.043","volume":"127","author":"X Wang","year":"2006","unstructured":"Wang X, Venable J, LaPointe P et al (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127:803\u2013815. https:\/\/doi.org\/10.1016\/j.cell.2006.09.043","journal-title":"Cell"},{"key":"3448_CR47","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature15729","volume":"528","author":"S Pankow","year":"2015","unstructured":"Pankow S, Bamberger C, Calzolari D et al (2015) \u2206F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature 528:510\u2013516. https:\/\/doi.org\/10.1038\/nature15729","journal-title":"Nature"},{"key":"3448_CR48","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1128\/MCB.05517-11","volume":"31","author":"S Luz","year":"2011","unstructured":"Luz S, Kongsuphol P, Mendes AI et al (2011) Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity. Mol Cell Biol 31:4392\u20134404. https:\/\/doi.org\/10.1128\/MCB.05517-11","journal-title":"Mol Cell Biol"},{"key":"3448_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(92)90536-L","volume":"70","author":"G Pelicci","year":"1992","unstructured":"Pelicci G, Lanfrancone L, Grignani F et al (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93\u2013104. https:\/\/doi.org\/10.1016\/0092-8674(92)90536-L","journal-title":"Cell"},{"key":"3448_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0968-0004(96)10033-5","volume":"21","author":"L Bonfini","year":"1996","unstructured":"Bonfini L, Migliaccio E, Pelicci G et al (1996) Not all Shc\u2019s roads lead to Ras. Trends Biochem Sci 21:257\u2013261. https:\/\/doi.org\/10.1016\/S0968-0004(96)10033-5","journal-title":"Trends Biochem Sci"},{"key":"3448_CR51","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/emboj\/16.4.706","volume":"16","author":"E Migliaccio","year":"1997","unstructured":"Migliaccio E, Mele S, Salcini AE et al (1997) Opposite effects of the p52shc\/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 16:706\u2013716. https:\/\/doi.org\/10.1093\/emboj\/16.4.706","journal-title":"EMBO J"},{"key":"3448_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/46311","volume":"402","author":"E Migliaccio","year":"1999","unstructured":"Migliaccio E, Giorgio M, Mele S et al (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309\u2013313. https:\/\/doi.org\/10.1038\/46311","journal-title":"Nature"},{"key":"3448_CR53","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0959-437X(00)00146-5","volume":"10","author":"L Luzi","year":"2000","unstructured":"Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG (2000) Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10:668\u2013674. https:\/\/doi.org\/10.1016\/S0959-437X(00)00146-5","journal-title":"Curr Opin Genet Dev"},{"key":"3448_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmb.2004.10.038","volume":"345","author":"MT Uhlik","year":"2005","unstructured":"Uhlik MT, Temple B, Bencharit S et al (2005) Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 345:1\u201320. https:\/\/doi.org\/10.1016\/j.jmb.2004.10.038","journal-title":"J Mol Biol"},{"key":"3448_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1367-5931(97)80014-2","volume":"1","author":"SE Shoelson","year":"1997","unstructured":"Shoelson SE (1997) SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr Opin Chem Biol 1:227\u2013234. https:\/\/doi.org\/10.1016\/S1367-5931(97)80014-2","journal-title":"Curr Opin Chem Biol"},{"key":"3448_CR56","doi-asserted-by":"publisher","first-page":"a008987","DOI":"10.1101\/cshperspect.a008987","volume":"5","author":"MJ Wagner","year":"2013","unstructured":"Wagner MJ, Stacey MM, Liu BA, Pawson T (2013) Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol 5:a008987. https:\/\/doi.org\/10.1101\/cshperspect.a008987","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3448_CR57","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0962-8924(01)02154-7","volume":"11","author":"T Pawson","year":"2001","unstructured":"Pawson T, Gish GD, Nash P (2001) SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11:504\u2013511. https:\/\/doi.org\/10.1016\/S0962-8924(01)02154-7","journal-title":"Trends Cell Biol"},{"key":"3448_CR58","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1128\/mcb.14.8.5192","volume":"14","author":"AG Batzer","year":"1994","unstructured":"Batzer AG, Rotin D, Ure\u00f1a JM et al (1994) Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14:5192\u20135201. https:\/\/doi.org\/10.1128\/mcb.14.8.5192","journal-title":"Mol Cell Biol"},{"key":"3448_CR59","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1074\/jbc.271.9.4770","volume":"271","author":"V Mandiyan","year":"1996","unstructured":"Mandiyan V, O\u2019Brien R, Zhou M et al (1996) Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif. J Biol Chem 271:4770\u20134775. https:\/\/doi.org\/10.1074\/jbc.271.9.4770","journal-title":"J Biol Chem"},{"key":"3448_CR60","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/378584a0","volume":"378","author":"M-M Zhou","year":"1995","unstructured":"Zhou M-M, Ravichandran KS, Olejniczak ET et al (1995) Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378:584\u2013592. https:\/\/doi.org\/10.1038\/378584a0","journal-title":"Nature"},{"key":"3448_CR61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/15216540400013895","volume":"56","author":"A Farooq","year":"2004","unstructured":"Farooq A, Zhou M-M (2004) PTB or not to be: promiscuous, tolerant and Bizarro domains come of age. IUBMB Life 56:547\u2013557. https:\/\/doi.org\/10.1080\/15216540400013895","journal-title":"IUBMB Life"},{"key":"3448_CR62","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0969-2126(03)00134-5","volume":"11","author":"A Farooq","year":"2003","unstructured":"Farooq A, Zeng L, Yan KS et al (2003) Coupling of folding and binding in the PTB domain of the signaling protein Shc. Structure 11:905\u2013913. https:\/\/doi.org\/10.1016\/S0969-2126(03)00134-5","journal-title":"Structure"},{"key":"3448_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ppul.20168","volume":"39","author":"MD Amaral","year":"2005","unstructured":"Amaral MD (2005) Processing of CFTR: traversing the cellular maze\u2014how much CFTR needs to go through to avoid cystic fibrosis? Pediatr Pulmonol 39:479\u2013491. https:\/\/doi.org\/10.1002\/ppul.20168","journal-title":"Pediatr Pulmonol"},{"key":"3448_CR64","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1016\/j.jmb.2018.06.017","volume":"430","author":"DM Hutt","year":"2018","unstructured":"Hutt DM, Loguercio S, Campos AR, Balch WE (2018) A proteomic variant approach (ProVarA) for personalized medicine of inherited and somatic disease. J Mol Biol 430:2951\u20132973. https:\/\/doi.org\/10.1016\/j.jmb.2018.06.017","journal-title":"J Mol Biol"},{"key":"3448_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","volume":"560","author":"LW Plasschaert","year":"2018","unstructured":"Plasschaert LW, \u017dilionis R, Choo-Wing R et al (2018) A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560:377\u2013381. https:\/\/doi.org\/10.1038\/s41586-018-0394-6","journal-title":"Nature"},{"key":"3448_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-017-0512-1","volume":"10","author":"D Liu","year":"2017","unstructured":"Liu D, Mamorska-Dyga A (2017) Syk inhibitors in clinical development for hematological malignancies. J Hematol Oncol 10:145. https:\/\/doi.org\/10.1186\/s13045-017-0512-1","journal-title":"J Hematol Oncol"},{"key":"3448_CR67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.pupt.2007.06.002","volume":"21","author":"ES Masuda","year":"2008","unstructured":"Masuda ES, Schmitz J (2008) Syk inhibitors as treatment for allergic rhinitis. Pulm Pharmacol Ther 21:461\u2013467. https:\/\/doi.org\/10.1016\/j.pupt.2007.06.002","journal-title":"Pulm Pharmacol Ther"},{"key":"3448_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/156652410791065408","volume":"10","author":"CN Belcher","year":"2010","unstructured":"Belcher CN, Vij N (2010) Protein processing and inflammatory signaling in cystic fibrosis: challenges and therapeutic strategies. Curr Mol Med 10:82\u201394","journal-title":"Curr Mol Med"}],"updated-by":[{"DOI":"10.1007\/s00018-024-05360-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-020-03448-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T04:10:42Z","timestamp":1722485442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-020-03448-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":68,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3448"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03448-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00018-024-05360-7","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00018-024-05360-7","URL":"https:\/\/doi.org\/10.1007\/s00018-024-05360-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}